Ha habido 50 transacciones internas recientes registradas para RAPT Therapeutics, Inc. (RAPT), incluyendo 35 compras y 13 ventas. El total de compras internas fue valorado en $27.7M y el total de ventas internas en $7.9M.
Internos destacados con actividad reciente incluyen Braunstein Scott, Young Rodney Kb, Ho William. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RAPT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-21 |
Braunstein Scott |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-06-21 |
Braunstein Scott |
Director |
Concesión de RSU |
25,000 |
$7.43 |
$185.75K |
25,000 |
| 2025-06-20 |
Young Rodney Kb |
Chief Financial Officer |
Concesión de RSU |
118,750 |
$7.43 |
$882.31K |
118,750 |
| 2025-06-20 |
Ho William |
Chief Medical Officer |
Concesión de RSU |
75,000 |
$7.43 |
$557.25K |
75,000 |
| 2025-06-20 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Concesión de RSU |
100,000 |
$7.43 |
$743K |
100,000 |
| 2025-06-20 |
Wong Brian Russell |
President and CEO |
Concesión de RSU |
637,500 |
$7.43 |
$4.74M |
637,500 |
| 2025-05-29 |
Gray Mary Ann |
Director |
Concesión de RSU |
257,832 |
$0.93 |
$239.78K |
257,832 |
| 2025-05-29 |
Lyons-williams Lori |
Director |
Concesión de RSU |
257,832 |
$0.93 |
$239.78K |
257,832 |
| 2025-05-29 |
Giordano Michael F |
Director |
Concesión de RSU |
257,832 |
$0.93 |
$239.78K |
257,832 |
| 2025-05-29 |
Kozick Linda |
Director |
Concesión de RSU |
257,832 |
$0.93 |
$239.78K |
257,832 |
| 2025-03-31 |
Gray Mary Ann |
Director |
Concesión de RSU |
61,202 |
$1.22 |
$74.67K |
61,202 |
| 2025-03-31 |
Robbins Wendye |
Director |
Concesión de RSU |
49,432 |
$1.22 |
$60.31K |
49,432 |
| 2025-01-30 |
Young Rodney Kb |
Chief Financial Officer |
Concesión de RSU |
642,000 |
$1.14 |
$731.88K |
642,000 |
| 2025-01-30 |
Ho William |
Chief Medical Officer |
Concesión de RSU |
450,000 |
$1.14 |
$513K |
450,000 |
| 2025-01-30 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Concesión de RSU |
515,000 |
$1.14 |
$587.1K |
515,000 |
| 2025-01-30 |
Wong Brian Russell |
President and CEO |
Concesión de RSU |
1,746,000 |
$1.14 |
$1.99M |
1,746,000 |
| 2024-12-27 |
Medicxi Ventures Management (jersey) Ltd |
10 Percent Owner |
Desconocido |
- |
- |
- |
374,023 |
| 2024-12-23 |
Column Group Ii, Lp |
Other: Former 10% Owner |
Otro (Venta) |
1,599,417 |
$0.00 |
$159.94 |
- |
| 2024-11-13 |
Young Rodney Kb |
Chief Financial Officer |
Devolución de Acciones |
68,000 |
$29.05 |
$1.98M |
- |
| 2024-11-13 |
Ho William |
Chief Medical Officer |
Devolución de Acciones |
75,000 |
$24.75 |
$1.86M |
- |
| 2024-11-13 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Devolución de Acciones |
55,000 |
$19.86 |
$1.09M |
- |
| 2024-11-13 |
Wong Brian Russell |
President and CEO |
Devolución de Acciones |
60,000 |
$44.66 |
$2.68M |
- |
| 2024-05-23 |
Rieflin William Jl |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-05-22 |
Gray Mary Ann |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-05-22 |
Lyons-williams Lori |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-05-22 |
Giordano Michael F |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-05-22 |
Kozick Linda |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-05-22 |
Robbins Wendye |
Director |
Concesión de RSU |
36,490 |
$4.63 |
$168.95K |
36,490 |
| 2024-03-28 |
Rieflin William Jl |
Director |
Concesión de RSU |
11,871 |
$8.98 |
$106.6K |
11,871 |
| 2024-03-28 |
Gray Mary Ann |
Director |
Concesión de RSU |
8,574 |
$8.98 |
$76.99K |
8,574 |
| 2024-03-28 |
Robbins Wendye |
Director |
Concesión de RSU |
6,925 |
$8.98 |
$62.19K |
6,925 |
| 2024-01-31 |
Young Rodney Kb |
Chief Financial Officer |
Concesión de RSU |
90,000 |
$24.75 |
$2.23M |
90,000 |
| 2024-01-31 |
Ho William |
Chief Medical Officer |
Concesión de RSU |
75,000 |
$24.75 |
$1.86M |
75,000 |
| 2024-01-31 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Concesión de RSU |
75,000 |
$24.75 |
$1.86M |
75,000 |
| 2024-01-31 |
Wong Brian Russell |
President and CEO |
Concesión de RSU |
275,000 |
$24.75 |
$6.81M |
275,000 |
| 2024-01-05 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Venta Informativa |
898 |
$22.78 |
$20.46K |
27,820 |
| 2023-12-29 |
Brockstedt Dirk G. |
Chief Scientific Officer |
Ejercicio de Opciones |
8,000 |
$6.18 |
$49.44K |
7,690 |
| 2023-12-21 |
Ho William |
Chief Medical Officer |
Venta Informativa |
2,500 |
$21.68 |
$54.2K |
15,020 |
| 2023-11-28 |
Ho William |
Chief Medical Officer |
Venta Informativa |
1,500 |
$13.72 |
$20.58K |
17,520 |
| 2023-10-03 |
Ho William |
Chief Medical Officer |
Venta Informativa |
2,500 |
$15.77 |
$39.43K |
18,789 |
| 2023-08-18 |
Ho William |
Chief Medical Officer |
Venta Informativa |
2,500 |
$18.92 |
$47.3K |
21,289 |
| 2023-07-28 |
Ho William |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
460 |
$12.00 |
$5.52K |
1,841 |
| 2023-06-23 |
Ho William |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
920 |
$12.00 |
$11.04K |
2,301 |
| 2023-05-24 |
Rieflin William Jl |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-05-24 |
Gray Mary Ann |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-05-24 |
Lyons-williams Lori |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-05-24 |
Giordano Michael F |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-05-24 |
Kozick Linda |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-05-24 |
Robbins Wendye |
Director |
Concesión de RSU |
12,940 |
$20.93 |
$270.83K |
12,940 |
| 2023-04-19 |
Ho William |
Chief Medical Officer |
Venta Informativa |
5,000 |
$18.88 |
$94.4K |
20,992 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
